WeVote
Log In

Bill

Bill

SF 52

Dispensing fee requirements establishment on health plan companies and county-based purchasing plans providing prescription drug coverage in the medical assistance program

2025-2026 Regular Session Introduced by Glenn Gruenhagen

Minnesota bill establishing dispensing fee requirements for prescription drug plans under Medicaid to ensure pharmacy reimbursement adequacy.

Referred to Health and Human Services
#drugsandmedicine #humanservicesandhumanservicesdepartment #insurance-health
0
WeVote Research Nonpartisan
Bill Summary · SF 52

Legislative bill overview

SF 52 establishes requirements for health plan companies and county-based purchasing plans that provide prescription drug coverage under Minnesota's Medical Assistance Program (Medicaid) to set dispensing fees for pharmacies. The bill appears to mandate minimum or standardized dispensing fee structures for these plans, affecting how much pharmacies are reimbursed for filling prescriptions for low-income Minnesotans.

Why is this important

Dispensing fees are a critical component of pharmacy reimbursement and directly affect whether independent and small pharmacies can remain economically viable, particularly in rural areas. The policy influences pharmacy access for Medicaid beneficiaries and the overall cost of the state's medical assistance program, as inadequate reimbursement can lead to pharmacy closures and reduced medication access for vulnerable populations.

Potential points of contention

  • Pharmacy economics vs. plan costs: Establishing higher dispensing fee requirements increases costs for health plans, which may be passed to taxpayers or result in reduced coverage elsewhere; conversely, insufficient fees threaten pharmacy viability
  • Rural vs. urban impacts: Fee requirements may disproportionately affect rural pharmacies with higher operating costs and lower prescription volumes, creating geographic healthcare access disparities
  • Standardization concerns: Mandatory one-size-fits-all fee structures may not account for regional cost variations or different pharmacy operational models, potentially disadvantaging some providers while over-compensating others

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.